This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Korea Institute of Science and Technology, Royal Bijou. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2018
Title: In Jae Shin: Innovator in Anticancer Agents and Temperature Control Technology
Introduction
In Jae Shin is a notable inventor based in Seoul, South Korea. He has made significant contributions to the fields of medicinal chemistry and temperature control technology. With a total of 2 patents, his work focuses on developing innovative solutions that address critical challenges in healthcare and logistics.
Latest Patents
One of In Jae Shin's latest patents is for a compound titled "4-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitors." This invention relates to a novel compound that serves as an anticancer agent, containing the compound as an active ingredient and an intermediate compound for preparing the compound. Another significant patent is for a "Portable temperature controlled container." This invention features a body with an internal chamber and a temperature control unit designed to selectively alter the temperature within the chamber by releasing a thermally controlled material.
Career Highlights
In Jae Shin has worked with reputable organizations, including Royal Bijou and the Korea Institute of Science and Technology. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research and development projects.
Collaborations
Some of his notable coworkers include Tae Bo Sim and Ho Jong Yoon. Their collaborative efforts have likely played a role in advancing the innovative projects they have worked on together.
Conclusion
In Jae Shin's contributions to the fields of anticancer agents and temperature control technology highlight his role as a significant inventor. His patents reflect a commitment to innovation that addresses pressing needs in healthcare and logistics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
